by Five Rivers Rx | Oct 7, 2020 | NABP
NABP has released a new version of its Policy and Procedure Assessment for Drug Distributor Accreditation. We analyzed the 4 removed standards and provide insight on the 10 new/revised standards. Background: Policies and Procedures (P&P) are the true backbone of...
by Five Rivers Rx | Jan 3, 2019 | Industry News, NABP
Three generic drug wholesalers, Oak Drugs (“Oak”), Matrix Distributors (“Matrix”), and Primed Pharmaceuticals (“Primed”) are challenging Optum Rx’s VAWD Requirement. The plaintiffs have recently received encouraging news from the U.S District Court for the District of...
by Five Rivers Rx | Dec 6, 2017 | NABP
Companies are starting to line up for a class action suit against the NABP, potentially reaching over 50 organizations across the United States. Background on the VAWD Standard It is VAWD standard that companies are “regularly establishing that prescription drugs...
by Five Rivers Rx | May 1, 2017 | NABP, Optum Rx, VAWD
The NABP has clarified that a “Cancelled” application does not equate to a “Denied” application. With the clarification, OptumRX should not have any basis to deny extensions under their VAWD requirement. Because there is no “change in…status that would...
by Five Rivers Rx | Apr 11, 2017 | NABP, Optum Rx, VAWD
In a stunning reversal of their existing course of conduct, the NABP has canceled a VAWD Application citing “pharmacy purchases” for the first time ever. The NABP has historically attempted to guide applicants and bring them up to standard via Application...
by Five Rivers Rx | Sep 26, 2016 | NABP, VAWD
In this week’s post, we explore how the NABP is potentially setting a double-standard as it applies its rules to the Big 3 versus independent distributors. ABC and Walgreens Tie-Up: In a press release dated March 19, 2013, AmerisourceBergen Corporation (ABC)...
